Abstract
Although aging of the brain is often associated with disease, it has been demonstrated that more than 70% of old people lives until death without evident signs of cerebral pathology. The so-called well preserved aged show a slight impairment of many psychological and neurological functions. Over the past ten years, a few significant concepts rose from studies on neurotransmitters and receptors in the aged brain: the plasticity of neurons and synapses, a neuronal hierarchy, a differential vulnerability and the so-called threshold phenomena (Bergener et al., 1985; Walker et al., 1983). Studies on plasticity of neurons and synaptogenesis are one of the most encouraging field for understanding normal and pathological aging and for generating drugs which can help to avert and to treat diseases. An increased dendritic synaptogenesis has been reported in neocortex following complex environment exposure both in adult and old rats (Greenough W., 1984). Although this event may diminish in senescent animals, the data suggest that the capacity for experience-dependent synaptogenesis is maintained through a significant proportion of the life-span. This is of particular interest for learning and memory. In fact, such a synaptic efficiency may well be a nuerophysiological mechanism for storage of information in the central nervous system.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bacopulos N. G. (1981) Acute changes in the state of dopamine receptors; in vitro monitoring with 3H-dopamine. Life Sci 29: 2407–2414
Bergener M., Ermini M., Stahelin H. B. (eds.) (1985) Thresholds in Aging, Academic Press, London
Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Scitelberger F. (1973) Brain dopamine and the syndrome of Parkinson and Huntington. J Neurol Sci 20: 415–455.
Creese I. and Snyder S. H. (1978) 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 49: 201–202
De Camilli P., Macconi D., Spada A. (1979) Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 278: 252–254
Giorgi O., De Montis M. G. Calderini G., Toffano G., Biggio G. (1986) Postnatal development of D-l dopamine receptors in rat striatum. Soc Neurosci Abstr 12: 987
Govoni S., Loddo P., Spano P. F., Trabucchi M. (1977) Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res 138: 565–571.
Greenough W. (1984) Structural correlates of information storage in the mammalian brain: a review and hypothesis. Trends Neurosci 7: 229–233.
Hahn R. A., Wardell J. R. Jr, Saran H. M., Ridely P. T. (1982) Characterization of the peripheral and central effects of SKF 82526 a novel dopamine receptor agonist. J Pharm Exp Ther 223: 305–313
Hornykiewicz O. (1979) Brain dopamine in Parkinson’s disease and other neurological disturbances. In: Neurobiology of Dopamine ( Horn S. A., Korf J., Westerink B. H. C. eds.) pp 633–654, Academic Press, London
Iorio L. C., Barnett A., Leitz F. H., Houser V. P., Korduba C. A. (1983) SCH 23390, a potential benzazepine antipsychotic with unique interaction on dopaminergic system. J Pharm Exp Ther 226: 462–468
Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277: 252–254.
Lee T., Seeman P., Rajput A., Farely I. J., Hornykiewicz O. (1978) Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 273: 59–61
Leysen J. E., Gommeren W., Laduron P. (1978) Spiperone: a ligand of choice for neuroleptic receptors 1. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27: 307–316
Memo M., Lucchi L., Spano P. F., Trabucchi M. (1980) Aging process affects a single class of dopamine receptor. Brain Res 202: 488–492
Morgan D. G., Marcusson J. O., Winblad B., Finch C. E: (1984) Reciprocal changes in D-l and D-2 dopamine binding sites in human caudate nucleus and putamen during normal aging. Soc Neurosci Abstr 10: 445.
O’Boyle K. H. and Waddington J. L. (1984) Loss of striatal dopamine receptors with aging is selective for D-2 but not D-l sites: association with increased non-specific binding of the D-l ligand 3H-piflutixol. Eur J Pharmacol 105: 171–174.
Onali P. L., Olianas M. C., Gessa G. L. (1985) Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol Pharmacol 28: 138–145.
Palacios J. M., Niehroff D. L., Kuhar M. J. (1981) 3H-spiperone binding sites in brain: autoradiographic localization of multiple receptors. Brain Res 213, 277–289
Peroutka S. J., U’Prichard D. C., Greenberg D. A., Snyder S. H. (1977) Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16: 549–556
Pradhan S. N. (1980) Central Neurotransmitters and aging. Life Sci 26: 1643–1656
Puri S. K. and Volicer L. (1976) Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum. Mech Aging and Develop 6: 53–58
Roth G. S. and Joseph J. A. (1985) Modulation of changes in dopaminergic receptors and responsiveness during aging. In: Thresholds In Aging ( Bergener M., Ermini M., Stahelin H. B. eds.) Academic Press, London
Schmidt M. J. and Thornberry J. F. (1978) Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old, and aged rats. Brain Res 139: 169–177.
Seeman P. (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313
Severson J. A. and Finch C. E. (1980) Reduced dopaminergic binding during aging in the rodent striatum. Brain Res 192: 147–162
Severson J. A., Marcusson J., Winbald B., Finch C. E. (1982) Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 39: 1623–1631.
Spano P. F., Govoni S., Trabucchi M. (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 19: 155–165.
Stoof J. C. and Kebabian J. W. (1981) Opposing roles for D-l and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366–368.
Thai L. J., Horowitz S. G., Dvorkin B., Makman M. H. (1980) Evidence for loss of brain 3H-ADTN binding sites in rabbit brain with aging. Brain Res 192: 185–194.
Walker R. F. and Cooper R. L. (eds.) (1983) Experimental and Clinical Interventions in Aging, Dekker, New York.
Wong D. F., Wagner H. N., Dannals R. F., Links J. M., Frost J. J., Ravert H. T., Wilson A. A., Rosenbaum A. E., Gjedde A., Douglass K. H., Petronis J. D., Folstein M. F., Toung J. K. T., Burns H. D., Khuar M. J. (1984) Effects of age on dopamine and serotonine receptors measured by positron emission tomography in the living human brain. Science 226: 1393–1396.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Missale, C., Memo, M., Spano, P.F. (1987). Dopaminergic System in the Aged Brain: Evidence for a Selective Loss of D-1 But Not D-2 Receptors. In: Govoni, S., Battaini, F. (eds) Modification of Cell to Cell Signals During Normal and Pathological Aging. NATO ASI Series, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72729-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-72729-0_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72731-3
Online ISBN: 978-3-642-72729-0
eBook Packages: Springer Book Archive